pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?

Clinical Trials 103

Clinical Trials Clinical Trials Trials Engineer 103

pharmaphorum

JULY 14, 2022

That could include original observations and measurements of clinical study participants, such as lab results, imaging data, and patient medical charts. It has been quick to give reassurance that any analysis of patient data will comply with the EU’s data protection requirements.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Regulation 52

Pharmaceutical Technology

NOVEMBER 9, 2022

According to a recent GlobalData report, healthcare professionals have – for the second year in a row – ranked artificial intelligence (AI) and Big Data as the top two technologies revolutionising the pharmaceutical sector. The legacy of this disruption has been a rethink in the way pharma companies do business.

Big Data 130

Big Data Manufacturing Packaging Packaging 130

Drug Discovery World

DECEMBER 27, 2023

In this episode, Kelland shares what she means by the ‘next pandemic’, the lessons learnt from the Covid-19 pandemic, and the role of global health organisations and pharma companies going forward. A deep dive into US drug discovery What lies in the future for genomics and big data? Listen here.

Clinical Trials 69

Clinical Trials Clinical Trials Drugs Development 69

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Pharma Companies 113

Pharma Companies Sales Vaccination Vaccine 113

Drug Discovery World

AUGUST 22, 2023

Originator pharma companies are developing ever more complex products, which are transforming the medical landscape, but their cost places an increasing burden on healthcare budgets worldwide. Opportunities Originator pharma companies are developing more and more complex products these days.

Production 52

Production Bioequivalency In-Vivo In-Vitro 52

pharmaphorum

FEBRUARY 11, 2022

During the pandemic, numerous digital health companies flourished due to the necessity for virtual solutions, including Komodo Health. He oversees operations, including business development, sales and marketing, and people. About the author.

Life Science 104

Life Science Engineer Development Big Data 104

pharmaphorum

MAY 30, 2022

.” The partners stress that this novel approach, paired with the “explosion in availability and accessibility of real-world data and real-world evidence”, as Sun states, creates an opportunity to use this new technique to supplement the evidence traditionally generated from clinical trial control groups.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Big Data 97

Drug Discovery World

FEBRUARY 6, 2024

Biopharma and biotech companies without these capabilities are keen to harness these technologies and the number of strategic partnerships with such companies is accelerating at an unprecedented rate.

Marketing 69

Marketing Medicine Genome Genomics 69

Cloudbyz

SEPTEMBER 25, 2020

Time is also of the essence in drug development, as competitive product-to-market lead times help pharma companies improve profitability. With the advancement in digital technologies, data collection from end-users enables pharma companies to take notice of certain trends.

Pharma Companies 52

Pharma Companies Big Data Drugs Clinical Trials 52

pharmaphorum

FEBRUARY 16, 2021

They had to be nurtured and cared for, despite the fact we, as pharma companies, have very limited direct access to patients. ” What is different is that today we share cloud-based infrastructure and tools with non-pharma companies, like FMCG. Even when the willingness was there, it was just technically impossible.

Marketing 106

Marketing Big Data Production Pharma Companies 106

pharmaphorum

DECEMBER 22, 2021

The ‘PEP Talks’ monthly e-newsletter has approaching 50 pharma companies as subscribers and the inaugural ‘Patient Engagement Day’ on September 01 st achieved an inspirational number of downloads of toolkits for ways to ‘Amplify the Patient Voice’ as the launch theme. Will pharma listen, and is this even their role to do so?

Clinical Trials 104

Clinical Trials Clinical Trials Trials Pharma Companies 104

Pharma Marketing Network

JUNE 11, 2020

And when you look through who those Twitter followers are, it’s very heavily skewed towards industry, as is the website, we’ve also put some tools on our website to be able to look at who the visitors are, by company. Don Langsdorf (EHS): 141 different pharma companies from around the world. John Mack (PG): Yeah.

Marketing 52

Marketing Branding Regulation Production 52

Pharmaceutical Technology

FEBRUARY 15, 2023

Big data analysis can be enormously powerful in providing insights for business strategy throughout the pharma value chain, including in the acceleration of drug discovery and development, optimization of manufacturing processes, management of supply chains and the creation of innovative sales and marketing strategies.

Big Data 130

Big Data Manufacturing Production Vaccination 130